Momelotinib: US approves GSK’s bone marrow cancer therapy
British drugmaker GSK said on Friday the U.S. Food and Drug Administration had approved its… Read More
2 years ago
British drugmaker GSK said on Friday the U.S. Food and Drug Administration had approved its… Read More